LFG
KNSA icon

Larson Financial Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Larson Financial Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3K Buy
1,052
+4
+0.4% +$207 ﹤0.01% 1382
2026
Q1 		$50.5K Buy
1,048
+636
+154% +$28.2K ﹤0.01% 1347
2025
Q4 		$17K Buy
412
+75
+22% +$3.01K ﹤0.01% 1808
2025
Q3 		$13.1K Buy
+337
New +$10.9K ﹤0.01% 1882
2025
Q2 		– Sell
-33
Closed -$733 – 3400
2025
Q1 		$733 Buy
+33
New +$679 ﹤0.01% 2470

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Larson Financial Group's KNSA Position: Q2 2026 in Review

Larson Financial Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 0.38% in Q2 2026, buying an estimated $207 and bringing the position to 1,052 shares worth $67.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Larson Financial Group first reported a position in KNSA in Q1 2025 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Larson Financial Group held 1,052 shares of Kiniksa Pharmaceuticals worth $67.3K as of Q2 2026.
  • Larson Financial Group bought 4 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $207.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1382 holding.
  • Larson Financial Group first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.